---
title: "Vraylar (cariprazine) in major depressive disorder: Drug interactions questions"
description: "Drug interactions questions on Vraylar (cariprazine) in major depressive disorder, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What Vraylar dose is used with a CYP3A4 inhibitor? Does Vraylar need extra monitoring when combined with an SRI antidepressant? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder/drug-interactions"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Vraylar (cariprazine) in major depressive disorder: Drug interactions questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Vraylar](https://www.rxabbvie.com/pdf/vraylar_pi.pdf)

Drug interactions questions that apply to every indication of Vraylar are on [Vraylar (cariprazine), all indications: Drug interactions](https://www.evicenter.com/medical-information/vraylar/drug-interactions).

## Drug interactions

<a id="vraylar-cyp3a4-inhibitor-dose"></a>

### What Vraylar dose is used with a CYP3A4 inhibitor?

> “Low doses are available for patients taking strong or moderate CYP3A4 inhibitors”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=Low%20doses%20are%20available%20for%20patients%20taking%20strong%20or%20moderate%20CYP3A4%20inhibitors)

> “Initiating strong CYP3A4 inhibitor while on a stable dose of VRAYLAR in adult and pediatric patients
>
> For patients currently taking VRAYLAR 1.5 or 3 mg once daily, adjust VRAYLAR dosage to 0.5 mg once daily”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=Initiating%20strong%20CYP3A4%20inhibitor%20while,to%200.5%20mg%20once%20daily)

> “Initiating VRAYLAR therapy while already on a strong CYP3A4 inhibitor
>
> Bipolar I depression and as adjunctive therapy to antidepressants for MDD: VRAYLAR starting dose is 0.5 mg once daily”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=Initiating%20VRAYLAR%20therapy%20while%20already,is%200.5%20mg%20once%20daily)

> “Initiating moderate CYP3A4 inhibitor while on a stable dose of VRAYLAR in adult and pediatric patients
>
> For patients currently taking VRAYLAR 1.5 or 3 mg once daily, adjust VRAYLAR dosage to 0.75 mg once daily”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=Initiating%20moderate%20CYP3A4%20inhibitor%20while,to%200.75%20mg%20once%20daily)

> “Initiating VRAYLAR while already on a moderate CYP3A4 inhibitor
>
> Bipolar I depression and as adjunctive therapy to antidepressants for MDD: VRAYLAR starting dose is 0.75 mg once daily”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=Initiating%20VRAYLAR%20while%20already%20on,is%200.75%20mg%20once%20daily)

> “When a strong or moderate CYP3A4 inhibitor is withdrawn, VRAYLAR dosage may need to be increased*”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=When%20a%20strong%20or%20moderate,may%20need%20to%20be%20increased%2A)

> “Concomitant use of VRAYLAR with a CYP3A4 inducer has not been evaluated and is not recommended”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=Concomitant%20use%20of%20VRAYLAR%20with,evaluated%20and%20is%20not%20recommended)

<a id="vraylar-sri-antidepressants"></a>

### Does Vraylar need extra monitoring when combined with an SRI antidepressant?

> “VRAYLAR does not require increased monitoring for serotonin reuptake inhibitor (SRI)-associated adverse events when used with an SRI<sup>1</sup>”

Source: [VRAYLAR: VRAYLAR® (cariprazine) Dosing Information, captured 2026-11-13](https://www.vraylarhcp.com/dosing#:~:text=VRAYLAR%20does%20not%20require%20increased,events%20when%20used%20with%20an)

## Related pages
- [Medical information: Vraylar (cariprazine): Major depressive disorder](https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder)
- [Indication](https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder/safety)
- [Specific populations](https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/vraylar--major-depressive-disorder/access-and-coverage)
